Evidence map›Paper›PMID 36869602›Full record

ArticleThoracic cancer2023

Clinical and genomic features of non-small cell lung cancer occurring in families.

Shingo Miyabe, Shin Ito, Ikuro Sato, Jiro Abe, Keiichi Tamai, Mai Mochizuki, Haruna Fujimori, Kazunori Yamaguchi, Norihisa Shindo, Hiroshi Shima and 4 more

Open access · goldAbstract read
In one paragraph

Article in Thoracic cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Shingo MiyabeDivision of Thoracic Surgery, Miyagi Cancer Center Hospital, Natori, Japan.
Shin ItoDivision of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, Natori, Japan.
Ikuro SatoDivision of Pathology, Miyagi Cancer Center Hospital, Natori, Japan.
Jiro AbeDivision of Thoracic Surgery, Miyagi Cancer Center Hospital, Natori, Japan.
Keiichi TamaiDivision of Cancer Stem Cell, Miyagi Cancer Center Research Institute, Natori, Japan.
Mai MochizukiDivision of Cancer Stem Cell, Miyagi Cancer Center Research Institute, Natori, Japan.
Haruna FujimoriDivision of Cancer Stem Cell, Miyagi Cancer Center Research Institute, Natori, Japan.
Kazunori YamaguchiDivision of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, Natori, Japan.
Norihisa ShindoDivision of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, Natori, Japan.
Hiroshi ShimaDivision of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Natori, Japan.ORCID 0000-0002-0857-8929
Tomoko YamazakiDivision of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, Natori, Japan.
Makoto AbueDivision of Cancer Stem Cell, Miyagi Cancer Center Research Institute, Natori, Japan.
Yoshinori OkadaDepartment of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Jun YasudaDivision of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, Natori, Japan.ORCID 0000-0002-3887-6871
Miyagi Prefectural Hospital Organization · JPTohoku Institute of Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExposure to environmental carcinogens, such as through smoking, is a major factor in the carcinogenesis of non-small cell lung cancer (NSCLC). However, genetic factors may also contribute.

methodsTo identify candidate tumor suppressor genes for NSCLC, we included 23 patients (10 related pairs and 3 individuals) with NSCLC who had other NSCLC-affected first-degree relatives in a local hospital. Exome analyses for both germline and somatic (NSCLC specimens) DNA were performed for 17 cases. Germline exome data of these 17 cases revealed that most of the short variants were identical to the variants in 14KJPN (a Japanese reference genome panel of more than 14 000 individuals) and only a nonsynonymous variant in the DHODH gene, p.A347T, was shared between a pair of NSCLC patients in the same family. This variant is a known pathogenic variant of the gene for Miller syndrome.

resultsSomatic genetic alterations in the exome data of our samples showed frequent mutations in the EGFR and TP53 genes. Principal component analysis of the patterns of 96 types of single nucleotide variants (SNVs) suggested the existence of unique mechanisms inducing somatic SNVs in each family. Delineation of mutational signatures of the somatic SNVs with deconstructSigs for the pair of germline pathogenic DHODH variant-positive cases showed that the mutational signatures of these cases included SBS3 (homologous recombination repair defect), SBS6, 15 (DNA mismatch repair), and SBS7 (ultraviolet exposure), suggesting that disordered pyrimidine production causes increased errors in DNA repair systems in these cases.

conclusionOur results suggest the importance of the detailed collection of data on environmental exposure along with genetic information on NSCLC patients to identify the unique combinations that cause lung tumorigenesis in a particular family.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsCarcinogenesisDihydroorotate DehydrogenaseGenomicsHumansMutationDihydroorotate DehydrogenaseDHODHexomemutational signaturenon-small cell lung cancertumor suppressor gene

Identifiers

PMID36869602
PMCPMC10067361
OpenAlexW4323066767

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.